Trademark Details For XENADRINE PURE (Serial Number 88067883)

  •  Home
  •  Print
XENADRINE PURE
2
12
8
0
Serial Number  United States - USPTO 88067883
Registration Number 5858634
Mark
XENADRINE PURE
Filing Date Aug-07-2018
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jun-2018

First Use in Commerce: Jun-2018





Correspondences

NameDouglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Address600 Atlantic Avenue Boston, MA 02210 UNITED STATES

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Aug-10-2018NEW APPLICATION ENTERED   NWAPI
Aug-13-2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Oct-15-2018ASSIGNED TO EXAMINER   DOCKD
Oct-16-2018EXAMINERS AMENDMENT -WRITTEN   CNEAR
Oct-16-2018EXAMINERS AMENDMENT E-MAILED   GNEAF
Oct-16-2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Oct-16-2018EXAMINER'S AMENDMENT ENTERED   XAECI
Oct-16-2018APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Oct-31-2018ASSIGNED TO LIE   ALIEA
Nov-21-2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Dec-11-2018PUBLISHED FOR OPPOSITION   PUBOA
Dec-11-2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Feb-05-2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jun-24-2019TEAS STATEMENT OF USE RECEIVED   EISUI
Jul-16-2019CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Jun-24-2019USE AMENDMENT FILED   IUAFS
Jul-16-2019STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Aug-05-2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Aug-06-2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Sep-10-2019REGISTERED-PRINCIPAL REGISTER   R.PRA
Sep-09-2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Sep-09-2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Sep-10-2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E